Hyperion Capital Advisors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Elevance Health
ELV
|
+$3.8M |
| 2 |
UnitedHealth
UNH
|
+$3.2M |
| 3 |
Meta Platforms (Facebook)
META
|
+$2.94M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$2.58M |
| 5 |
ARCE
Arco Platform Limited Class A Common Shares
ARCE
|
+$2.42M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Arista Networks
ANET
|
+$5.89M |
| 2 |
PPLI
People Inc
PPLI
|
+$285K |
| 3 |
Mastercard
MA
|
+$244K |
| 4 |
Wayfair
W
|
+$135K |
| 5 |
West Pharmaceutical
WST
|
+$15.2K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 53.51% |
| 2 | Communication Services | 14.13% |
| 3 | Industrials | 9.43% |
| 4 | Consumer Discretionary | 7.5% |
| 5 | Healthcare | 7.48% |
Similar funds
Hyperion Capital Advisors's Q2 2021 Portfolio in Review
As of Q2 2021, Hyperion Capital Advisors held 47 positions worth $350M, up 13% from $310M the previous quarter. Its ten largest holdings account for 84% of the portfolio.
Hyperion Capital Advisors deployed $15.1M of net new capital in Q2 2021, opening 3 new positions and adding to 11 existing holdings. Its largest new stake was Arco Platform Limited Class A Common Shares: 85,000 shares worth $2.61M.
By sector, the portfolio is most concentrated in Financials at 54% of assets, down from 55% a quarter earlier, followed by Communication Services and Industrials.
On the sell side, the largest reduction was Arista Networks, an estimated $5.89M trimmed.
- Hyperion Capital Advisors's largest Q2 2021 buy was Arco Platform Limited Class A Common Shares: 85,000 shares worth $2.61M.
- Hyperion Capital Advisors added most to Elevance Health in Q2 2021, an estimated $3.8M increase.
- Hyperion Capital Advisors's biggest Q2 2021 reduction was Arista Networks, cutting an estimated $5.89M.
- Hyperion Capital Advisors's ten largest holdings make up 84% of its $350M portfolio in Q2 2021.
- Hyperion Capital Advisors opened 3 new positions and closed 0 in Q2 2021.
- Hyperion Capital Advisors's portfolio value rose 13% quarter-over-quarter to $350M.
Based on Hyperion Capital Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.